EdRIP backs Edimark Santé OBO

Edimark president Claudie Damour-Terrasson secured a majority stake in the new structure. Ten managers also took a stake in the company. Private equity house Paluel-Marmont Capital, which backed the MBO of the business from Activa Capital in 2007, fully exited Edimark.

EdRIP invested via the Cabestan fund, a €112m FCPR closed in late 2011. The fund typically invests €1-7m per deal – this is the vehicle's third transaction.

Debt
The transaction was financed via a debt package arranged by LCL, Crédit du Nord and Banque Palatine. Trocadero Capital provided a €3m mezzanine financing package; this was the fund's first mezzanine investment.

Company
Edimark Santé publishes scientific publications targeting specialised healthcare professionals. Meanwhile Espace Information Dentaire produces four journals targeting dentists and other dental medicine professionals. The companies posted an aggregate turnover of €18m in 2011.

People
Pierre-Michel Passy, Mayeul Caron and François-Xavier Mauron worked on the deal for EdRIP. Xavier Poppe and François-Xavier Deren led the exit for Paluel-Marmont.

Advisers
Equity – Frieh Bouhenic, Jeremy Scemama, Maud Manon, Camille Lagache, Benjamin Marché (Legal, tax); AEC Partners, Rodolphe Gobe (Commercial due diligence); Exelmans, Stéphane Dahan (Financial due diligence); Reed Smith, Marina Cousté (Regulation due diligence).
Vendor & management – XK Corporate Finance, Alain Pichot, François Poupée (Corporate finance); Woog & Associés, Frédéric Lafond, Christophe Court (Legal); Grégoire Halpern (Legal).
Debt – Delsol Avocats, Frédéricque Milotic (Legal).
Mezzanine – GGSM, Marc Baffreau (Legal).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• France
• Buyouts
• Media
• Now researching
• Exits
• France
• Andera Partners